Atopic Dermatitis Research Trial (30 Weeks)

Adults and adolescents (≥12 to < 18 years of age and weighing ≥40 kg) with chronic atopic dermatitis (AD) present for 1 year or more, may be eligible to participate. Individuals must have moderate to severe atopic dermatitis with AD involvement of 10% or greater body surface area. A history of inadequate response to treatment with topical medications is also required, among other required criteria.

Participants will receive investigational medication (active study drug) or placebo, via subcutaneous injection, combined with topical corticosteroid treatment. Study medication and study-related care will be provided at no cost. Reimbursement for certain study-related expenses will also be provided.

Study participation will last about 30 weeks and involve about 11 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Atopic Dermatitis
Register Now!

Participating Locations


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.


  • Sorry no locations are available in this country.

Register for
Active Studies!


All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more